A Non-Medication Solution for Chronic Pain
Chronic pain affects 100 million Americans and is the most common cause of long-term disability. Long-term use of pain medications has significant risks, and chronic pain is a major contributor to opioid overuse.
Quell Wearable Pain Relief
NeuroMetrix hopes to offer effective, non-medication solutions for chronic pain. The Waltham, MA-based company has developed the Quell wearable device, which uses principles of neurostimulation to decrease the sensation of chronic pain. In a newly published study, 4 out of 5 users reported decreased pain after 60 days of use.
We spoke with NeuroMetrix founder and CEO Shai Gozani, MD, PhD, to find out more about the product and the company.
Cici Zhou, Medgadget: What made you interested in neurotechnology and pain relief?
Dr. Gozani: I founded NeuroMetrix Inc., in 1996 as a spin-off from my time at the Harvard-MIT Division of Health Sciences and Technology where I received my M.D. Our first product was a prescription diagnostic product used in doctors’ offices. We’ve spent over 20 years developing neuro diagnostic technology and when we developed Quell, our wearable device for chronic pain, we recognized that the healthcare industry is becoming more and more consumer-driven, so we wanted to make it our pain relief technology accessible directly to the consumer. We launched the first generation of Quell in 2015 and just recently introduced our next generation device, Quell 2.0 in September.
Medgadget: How does Quell work?
Dr. Gozani: Quell is an 100% drug free, clinically-proven technology that activates the descending pain inhibition system. Our device stimulates the sensory nerves in your calf, sending neural pulses to your brain [and] triggering the release of endogenous opioids. The device is designed for multiple types and sources of chronic pain. Our new device, Quell 2.0, is 50% smaller compared to our first generation and 20% more powerful.
We're here for you.or call 800.204.6577